Sales and Marketing

Showing 15 posts of 11526 posts found.

hrw_esme_holt

HRW appoints Esme Holt and Rob Egerton

June 17, 2011 Medical Communications, Sales and Marketing appointment, medical communications, sales and marketing

Oxfordshire, UK-based market research company HRW has made two new appointments to its senior team. Esme Holt, who joined HRW …
Roche’s Avastin (bevacizumab)

NHS failed to use extra cancer drug funds

June 17, 2011 Sales and Marketing Cancer, Cancer Drugs Fund, Erbitux, avastin

The million pound fund set up to increase NHS uptake of new cancer drugs was widely underused, with just over …

Lundbeck to file alcoholism pill this year

June 16, 2011 Sales and Marketing Biotie, Lundbeck, alcohol

Lundbeck plans to submit its alcohol dependency treatment for European approval later this year after trials showed it to cut …

Spiriva mist inhaler safety concerns raised

June 16, 2011 Sales and Marketing Boehringer Ingelheim, Spiriva, drug safety

A mist inhaler used to deliver Spiriva to patients with chronic obstructive pulmonary disease (COPD) may be linked to an …
Boehringer Ingelheim and Lilly's diabetes drug Tradjenta

Boehringer-Lilly launch diabetes drug Tradjenta in US

June 16, 2011 Sales and Marketing Boehringer Ingelheim, Tradjenta, diabetes, lilly

Boehringer Ingelheim and Eli Lilly’s new type II diabetes treatment Tradjenta has been launched in the US. Tradjenta (linagliptin) is …

GSK takes control of China vaccines venture

June 15, 2011 Manufacturing and Production, Research and Development, Sales and Marketing China, GSK, Shenzhen Neptunus Interlong Bio-Technique Co, vaccines

GlaxoSmithKline is increasing its footprint in China, shelling out £24 million ($39 million) to buy the remaining stake in a …
ABPI social media internet guidelines

Digital Pharma: Pharmacovigilance, the internet and social media

June 15, 2011 Medical Communications, Research and Development, Sales and Marketing Digital Pharma blog, adverse event reporting, adverse events, pharmacovigilance

This week the ABPI released guidance on managing adverse events from social media and the internet in a document that …
Cephalon

Teva’s Cephalon acquisition could be delayed

June 15, 2011 Manufacturing and Production, Research and Development, Sales and Marketing Cephalon, Teva

The Federal Trade Commission has requested more information about Teva’s deal with Cephalon, potentially delaying the purchase by a month. …
Merck & Co

Merck to develop biosimilar of Pfizer’s Enbrel

June 15, 2011 Research and Development, Sales and Marketing Enbrel, Merck & Co, biosimilar

Merck & Co is to develop its own version of Pfizer’s ageing arthritis drug Enbrel with a South Korean manufacturer. …
Blog footer

Digital Pharma: The rise of the European e-patient

June 14, 2011 Medical Communications, Sales and Marketing Digital Pharma blog, online health information

The number of people in Europe who go online to look for health information has more than doubled over the …

Daniel Elger joins e-Therapeutics

June 13, 2011 Research and Development, Sales and Marketing appointment, research and development, sales and marketing

UK and India-based e-Therapeutics has appointed Dr Daniel Elger as chief financial officer. He joins the drug discovery company from …
networks_in_health_beverly_stainsby

Networks in Health appoints Beverly Stainsby

June 13, 2011 Sales and Marketing appointment, sales and marketing

Beverly Stainsby has joined Networks in Health, an alliance of online doctors’ communities, as international account director. She joins from …

European pharma’s compliance challenge

June 13, 2011 Sales and Marketing global regulatory landscape, regulatory affairs, regulatory compliance

Life Sciences companies across Europe are facing a series of emerging global legislation and increased regulatory enforcement, designed to prevent …
GlaxoSmithKline

GSK’s epilepsy treatment Potiga wins US approval

June 13, 2011 Sales and Marketing GSK, Potiga, Trobalt, Valeant, epilepsy

The FDA has approved GlaxoSmithKline and Valeant’s epilepsy treatment Potiga, but the drug will require further review before it can …
Takeda Actos (pioglitazone)

France pulls Takeda diabetes drugs after cancer fears

June 13, 2011 Sales and Marketing Actos, Competact, EMA, Takeda

The French medicines agency has moved to prevent two Takeda diabetes drugs from being prescribed after fears they could increase …
The Gateway to Local Adoption Series

Latest content